These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 10941824)

  • 1. Active immunization of humans with dendritic cells.
    Dhodapkar MV; Bhardwaj N
    J Clin Immunol; 2000 May; 20(3):167-74. PubMed ID: 10941824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutual helper effect in copulsing of dendritic cells with 2 antigens: a novel approach for improvement of dendritic-based vaccine efficacy against tumors and infectious diseases simultaneously.
    Shojaeian J; Jeddi-Tehrani M; Dokouhaki P; Mahmoudi AR; Ghods R; Bozorgmehr M; Nikoo S; Bayat AA; Akhondi MM; Ostadkarampour M; Rezania S; Zarnani AH
    J Immunother; 2009 May; 32(4):325-32. PubMed ID: 19342973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced priming of antigen-specific CTLs in vivo by embryonic stem cell-derived dendritic cells expressing chemokine along with antigenic protein: application to antitumor vaccination.
    Matsuyoshi H; Senju S; Hirata S; Yoshitake Y; Uemura Y; Nishimura Y
    J Immunol; 2004 Jan; 172(2):776-86. PubMed ID: 14707047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Day 3 Poly (I:C)-activated dendritic cells generated in CellGro for use in cancer immunotherapy trials are fully comparable to standard Day 5 DCs.
    Truxova I; Pokorna K; Kloudova K; Partlova S; Spisek R; Fucikova J
    Immunol Lett; 2014 Jul; 160(1):39-49. PubMed ID: 24726860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity.
    He Y; Zhang J; Mi Z; Robbins P; Falo LD
    J Immunol; 2005 Mar; 174(6):3808-17. PubMed ID: 15749922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy exploiting the versatility of dendritic cells.
    Kadowaki N
    Ther Apher Dial; 2003 Jun; 7(3):312-7. PubMed ID: 12924606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells as vectors for immunotherapy of cancer.
    Paczesny S; Ueno H; Fay J; Banchereau J; Palucka AK
    Semin Cancer Biol; 2003 Dec; 13(6):439-47. PubMed ID: 15001163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic and functional characterization of mature dendritic cells from pediatric cancer patients.
    Jacobs JF; Hoogerbrugge PM; de Rakt MW; Aarntzen EH; Figdor CG; Adema GJ; de Vries IJ
    Pediatr Blood Cancer; 2007 Dec; 49(7):924-7. PubMed ID: 17486645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell-based immunotherapy.
    Berger TG; Schultz ES
    Curr Top Microbiol Immunol; 2003; 276():163-97. PubMed ID: 12797448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Manipulating dendritic cell biology for the active immunotherapy of cancer.
    O'Neill DW; Adams S; Bhardwaj N
    Blood; 2004 Oct; 104(8):2235-46. PubMed ID: 15231572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dendritic cells as vectors for vaccination against infectious diseases.
    Moll H; Berberich C
    Int J Med Microbiol; 2001 Nov; 291(5):323-9. PubMed ID: 11727816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strategies for improved antigen delivery into dendritic cells.
    Rea D; Johnson ME; Havenga MJ; Melief CJ; Offringa R
    Trends Mol Med; 2001 Mar; 7(3):91-4. PubMed ID: 11286763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dendritic Cells and Cancer Immunity.
    Gardner A; Ruffell B
    Trends Immunol; 2016 Dec; 37(12):855-865. PubMed ID: 27793569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of dendritic cells for cancer vaccination.
    Esche C; Shurin MR; Lotze MT
    Curr Opin Mol Ther; 1999 Feb; 1(1):72-81. PubMed ID: 11249687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current issues in dendritic cell cancer immunotherapy.
    López JA; Hart DN
    Curr Opin Mol Ther; 2002 Feb; 4(1):54-63. PubMed ID: 11885565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Eliciting cytotoxic T lymphocytes against human laryngeal cancer-derived antigens: evaluation of dendritic cells pulsed with a heat-treated tumor lysate and other antigen-loading strategies for dendritic-cell-based vaccination.
    Wei FQ; Sun W; Wong TS; Gao W; Wen YH; Wei JW; Wei Y; Wen WP
    J Exp Clin Cancer Res; 2016 Jan; 35():18. PubMed ID: 26795730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing dendritic cell-based immunotherapy: tackling the complexity of different arms of the immune system.
    Van Brussel I; Berneman ZN; Cools N
    Mediators Inflamm; 2012; 2012():690643. PubMed ID: 22851815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dendritic cells in cancer immunotherapy.
    Gunzer M; Grabbe S
    Crit Rev Immunol; 2001; 21(1-3):133-45. PubMed ID: 11642600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cord blood stem-cell-derived dendritic cells generate potent antigen-specific immune responses and anti-tumour effects.
    Chang MC; Lee CN; Chen YL; Chiang YC; Sun WZ; Hu YH; Chen CA; Cheng WF
    Clin Sci (Lond); 2012 Sep; 123(6):347-60. PubMed ID: 22264240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetically modified dendritic cells in cancer therapy: implications for transfusion medicine.
    Foley R; Tozer R; Wan Y
    Transfus Med Rev; 2001 Oct; 15(4):292-304. PubMed ID: 11668436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.